Indirect treatment comparison of lanadelumab and a C1-esterase inhibitor in pediatric patients with hereditary angioedema
Journal of Comparative Effectiveness Research · 2025
DOI: 10.57264/cer-2024-0110 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Comparative Effectiveness Research, 2025. Verfasst von Maureen Watt und 3 weiteren Autor:innen. Beteiligte Einrichtung: Takeda Development Center Americas, Inc., Lexington, MA 02421, USA. Hauptthemen laut MEDLINE: Angioedemas, Hereditary, Complement C1 Inhibitor Protein, Antibodies, Monoclonal, Humanized. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Aim: To compare the efficacy and safety of lanadelumab versus other approved long-term prophylaxis (LTP) treatments in patients with pediatric hereditary angioedema (HAE) aged
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Takeda Development Center Americas, Inc., Lexington, MA 02421, USA.
- ICON plc, Insights, Evidence & Value - Health Economics & Epidemiology, Vancouver, British Columbia, Canada.
- ICON plc, Insights, Evidence & Value - Health Economics & Epidemiology, Stockholm, Sweden.
- ICON plc, Insights, Evidence & Value - Health Economics & Epidemiology, Langen, Germany.
ORCID-Profile: Maureen Watt, Rachel Goldgrub, Mia Malmenäs
Zitieren
APA
Watt, M., Goldgrub, R., Malmenäs, M., & Haeussler, K. (2025). Indirect treatment comparison of lanadelumab and a C1-esterase inhibitor in pediatric patients with hereditary angioedema. Journal of Comparative Effectiveness Research. https://doi.org/10.57264/cer-2024-0110
Vancouver
Watt M, Goldgrub R, Malmenäs M, Haeussler K. Indirect treatment comparison of lanadelumab and a C1-esterase inhibitor in pediatric patients with hereditary angioedema. Journal of Comparative Effectiveness Research. 2025. doi:10.57264/cer-2024-0110
BibTeX
@article{Watt2025,
author = {Watt, Maureen and Goldgrub, Rachel and Malmenäs, Mia and Haeussler, Katrin},
title = {Indirect treatment comparison of lanadelumab and a C1-esterase inhibitor in pediatric patients with hereditary angioedema},
journal = {Journal of Comparative Effectiveness Research},
year = {2025},
doi = {10.57264/cer-2024-0110}
}
EUVIMED